Table:
begin	end	state
1	29	cytoplasmic
30	41	non-cytoplasmic
42	55	transmembrane
56	68	non-cytoplasmic
69	90	transmembrane
91	101	cytoplasmic
102	126	transmembrane
127	130	non-cytoplasmic
131	157	transmembrane
158	175	cytoplasmic
176	196	transmembrane
197	201	non-cytoplasmic
202	221	transmembrane
222	259	cytoplasmic
260	284	transmembrane
285	295	non-cytoplasmic
296	315	transmembrane
316	325	cytoplasmic
326	345	transmembrane
346	351	non-cytoplasmic
352	373	transmembrane
374	391	cytoplasmic
392	412	transmembrane
413	418	non-cytoplasmic
419	439	transmembrane
440	445	cytoplasmic

Input:
>WP_050464670.1 NCBI__GCF_001189915.1:WP_050464670.1
MKDVALNPGTDGLGQPPAAVAHDAKVGRRAVIAASTGNALEWYDFTVYALFAVYIGQNFF
KNDNPTVQLMGSFMAFGLGYVARPLGALLLGSYGDRAGRKAALTMTIMLMALGTLLIAIA
PPYAAIGIGAPLLIVCGRVLQGFSAGGEIGGATAFLVEHAPPEKKGQYASWLQASMGISN
VLGALVATIVTTVFTVDQIGEWAWRIPFIIGLAIAPVGLWMRKTLDETPHFKLEEARMKK
SGVEKKTPLLQVIRECPKQLLAGFGLSVLWAAGPYSLIIFMPIYVQKTMGFASSQAFLAA
FIGNFFLIGGCVFSGTLSDKLGRRTVLRIGAILLLVGVYPLMMWLQASHTTATLIIVQSL
FCAMISMFVGVAPSALSEIFPTAVRSSGMSLSYNTAVTLLGGFAPAILTWITYTTGVAFA
PALYVMVAAVIALIAISVLPEASKD

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server